# Coconut Milk-Derived Bioactive Peptides as Multifunctional Agents Against Hyperglycemia, Oxidative Stress, and Glycation: An Integrated Experimental and Computational Study

**Authors:** Akshaya Simha Naganarasimha, Shashank M. Patil, Ramith Ramu, Maciej Przybyłek, Piotr Bełdowski, Olga Małolepsza, Sławomir Bujanowski, Mudassar Shahid

PMC · DOI: 10.3390/ijms27010360 · International Journal of Molecular Sciences · 2025-12-29

## TL;DR

This study identifies peptides from coconut milk that may help manage diabetes by reducing high blood sugar, oxidative stress, and harmful chemical reactions.

## Contribution

The study discovers and validates multifunctional peptides from coconut milk with anti-diabetic and antioxidant properties using experimental and computational methods.

## Key findings

- ADVFNPR peptide inhibited key diabetic enzymes and showed strong antioxidant activity.
- Molecular dynamics confirmed stable binding of peptides to diabetic targets.
- Coconut milk peptides could serve as food-derived agents for managing T2DM and glycation-related complications.

## Abstract

Type 2 diabetes mellitus (T2DM) is characterised by chronic hyperglycaemia and accumulation of advanced glycation end products (AGEs), driving interest in food-derived peptides as safer multifunctional modulators. Coconut milk is a promising source, but its anti-hyperglycaemic and anti-glycation potential remains largely unexplored. Here, proteins from coconut cream, skimmed and insoluble fractions of coconut milk were enzymatically hydrolysed, and the resulting peptides were profiled by nano-ESI-Orbitrap-LC-MS/MS. One hundred and fourteen peptides were identified and screened in silico against α-glucosidase, α-amylase, aldose reductase and the receptor for AGEs (RAGE). Two peptides, MQIFVK and ADVFNPR, showed the most favourable docking scores and physicochemical properties. However, ADVFNPR inhibited all 3 diabetic targets & RAGE. Molecular dynamics analysis showed that both peptides bind stably to the diabetic targets. Both peptides were synthesised and evaluated in vitro. ADVFNPR significantly inhibited α-glucosidase, α-amylase and aldose reductase with lower IC50 values and displayed competitive inhibition kinetics. It also scavenged methylglyoxal, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) and superoxide radicals at low EC50 values, and showed low hemolytic activity in human erythrocytes. These findings indicate that coconut milk contains multifunctional peptides with anti-hyperglycaemic, anti-glycation and antioxidant activities that may be further developed as food-derived adjuncts for managing T2DM and glycation-related complications.

## Linked entities

- **Proteins:** AGER (advanced glycosylation end-product specific receptor)
- **Chemicals:** methylglyoxal (PubChem CID 880), ABTS (PubChem CID 35688)
- **Diseases:** Type 2 diabetes mellitus (MONDO:0005148), T2DM (MONDO:0005148)

## Full-text entities

- **Genes:** SI (sucrase-isomaltase) [NCBI Gene 6476], AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, AKR1B1 (aldo-keto reductase family 1 member B) [NCBI Gene 231] {aka ADR, ALDR1, ALR2, AR}
- **Diseases:** Hyperglycemia (MESH:D006943), hemolytic (MESH:D006461), diabetic (MESH:D003920), T2DM (MESH:D003924)
- **Chemicals:** superoxide (MESH:D013481), AGEs (MESH:D017127), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (MESH:C002502), methylglyoxal (MESH:D011765), ADVFNPR (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12785583/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12785583/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12785583/full.md

---
Source: https://tomesphere.com/paper/PMC12785583